Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Second Autologous Transplantation in AL Amyloidosis

NCT00075608 is registered in ClinicalTrials.gov with Boston Medical Center as lead sponsor.

NCT NCT00075608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00075608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Second Autologous Transplantation in AL Amyloidosis
Lead sponsor
Boston Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2001
Completion date
October 31, 2011
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma, plasma cell neoplasm